Furthermore, to demonstrate that bufalin acts as an anti-cancer agent specifically when ATP1A1 is located in caveolae, we used methyl-β-cyclodextrin (MBCD) to disrupt caveolae formation. The gene discussed is ATP1A1; the disease is cancer.